Epigenetic Drugs for Multiple Sclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|14|1|3-9

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.14, Iss.1, 2016-01, pp. : 3-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drugs Treatment of Pain in Multiple Sclerosis

By  

Current Clinical Pharmacology, Vol. 2, Iss. 3, 2007-09 ,pp. : 227-233

Bentham Science Publishers

Access to resources Recommend Favorite

Oral drugs for the treatment of Multiple Sclerosis

By  

PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. : 396-402

Govi-Verlag

Access to resources Recommend Favorite

Drugs in Clinical Development for Multiple Sclerosis: Summary and Table

By  

Pharmaceutical Medicine, Vol. 26, Iss. 2, 2012-04 ,pp. : 103-112

Adis International

Access to resources Recommend Favorite

Emerging oral drugs for relapsing–remitting multiple sclerosis

By Gasperini Claudio   Ruggieri Serena  

Expert Opinion on Emerging Drugs, Vol. 16, Iss. 4, 2011-12 ,pp. : 697-712

Informa Healthcare

Access to resources Recommend Favorite

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 610-623

Bentham Science Publishers

Access to resources Recommend Favorite